In the course of Sanger sequencing for the CYP21A2 gene downstream of the TNXB gene, the 46 patients with hyperandrogenemia were previously identified by our group as carriers for the p.Gln319Ter pathogenic variant (12, 31). This evidence concerns the gene CYP21A2 and polycystic ovary syndrome.